Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. [PDF]
Csizmarik A +16 more
europepmc +1 more source
Capivasertib Combination Therapy in Advanced Breast Cancer and Other Solid Tumors: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Biomarker-Defined Outcomes. [PDF]
Alasmari MM +5 more
europepmc +1 more source
Bone-related adverse events of hormonal therapy: A pharmacovigilance study based on the Food & Drug Administration Adverse Event Reporting System. [PDF]
Wang Y, Li A, Wang J, Xie M.
europepmc +1 more source
Metabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer. [PDF]
Shaver AL +5 more
europepmc +1 more source
Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors. [PDF]
Asiri IM +12 more
europepmc +1 more source
The role of the prognostic nutritional index at baseline and follow-up in patients with metastatic prostate cancer. [PDF]
Cengiz M +11 more
europepmc +1 more source
Related searches:
A novel spectrofluorimetric method to determine abiraterone acetate and its active metabolite, abiraterone was developed, based on the fact that fluorescence intensity of abiraterone acetate and abiraterone could be enhanced in β-cyclodextrin (β-CD) due to the formation of the inclusion complex. The inclusion interaction of β-CD and abiraterone acetate
Xiashi Zhu
exaly +3 more sources
Rapid Conversion of the Ester Prodrug Abiraterone Acetate Results in Intestinal Supersaturation and Enhanced Absorption of Abiraterone: In Vitro, Rat in Situ and Human in Vivo Studies [PDF]
The aim of this study was to evaluate the intestinal disposition of abiraterone acetate, an ester prodrug of the anticancer agent abiraterone. Stability of the prodrug and solubility and dissolution characteristics of both abiraterone and abiraterone ...
Jan Tack +2 more
exaly +2 more sources

